Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CANCER FUND (also known as CANCER FUND Impact Investments) is a venture capital firm and impact investment community based in Phoenix, Arizona, dedicated to accelerating the development and commercialization of early-stage cancer innovations. The firm operates as a community-based investment vehicle, allowing individual and institutional investors to fund promising oncology startups across three primary areas: therapies and management, diagnostics and monitoring, and prevention and enabling technologies. CANCER FUND focuses on high-impact, early-stage ventures (Pre-Seed to Series A) that aim to improve patient outcomes, increase access to care, and reduce the cost of cancer treatment. Its portfolio includes companies working on diverse modalities such as small molecule epigenetic medicines, novel immunotherapies, and advanced monitoring devices. By bridging the gap between academic research and clinical application, CANCER FUND seeks to move breakthrough cancer solutions beyond the lab and into the hands of patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cancer Fund.